Class / Patent application number | Description | Number of patent applications / Date published |
424263100 | Chlamydia (e.g., Chlamydia trachomatis, etc.) | 15 |
20080226679 | Novel surface exposed proteins from chlamydia pneumoniae - The invention relates to the identification of members of a gene family from the human respiratory pathogen | 09-18-2008 |
20090098165 | METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST CHLAMYDIAL INFECTION AND DISEASE - The present invention provides | 04-16-2009 |
20090142376 | CHLAMYDIA POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF - The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of | 06-04-2009 |
20090304751 | VAULT COMPOSITIONS FOR IMMUNIZATION AGAINST CHLAMYDIA GENITAL INFECTION - Methods and compositions are provided herein for immunizing a subject against Chlamydial genital infection by administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle carrier. In some aspects, the vault-like-particles are administered to the nasal mucosa. The methods and compositions advantageously exhibit enhanced ability to induce cell-mediated immunity and/or antibody-based immunity at mucosal surfaces while reducing inflammation associated with | 12-10-2009 |
20110027321 | Chlamydia Vaccine Comprising HtrA Polypeptides - The present invention provides vaccine compositions useful in prevention and treatment of | 02-03-2011 |
20110070266 | IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS - The invention relates to immunogenic compositions comprising combinations of | 03-24-2011 |
20110159041 | Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection - The subject of the invention is the genomic sequence and the nucleotide sequences encoding polypeptides of | 06-30-2011 |
20110293664 | CHLAMYDIA ANTIGENS AND USES THEREOF - Disclosed are novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. Methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses) comprising administering an immunogenic composition including one or more of the novel antigens may be used for prophylaxis and/or treatment of chlamydia-mediated diseases. | 12-01-2011 |
20120009220 | Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen - Disclosed are compositions, kits, and methods for inducing an immune response against disease. The dosage of antigen contained or utilized in the presently disclosed compositions, kits, and methods is substantially lower than dosages conventionally used in the field. The compositions, kits, and methods may be utilized to induce a cell-mediated response, such as a T-helper cell response, and/or a humoral response against a pathogen or a disease. In some embodiments, the compositions, kits, and methods may be utilized to induce preferentially a Th1 response versus other types of immune responses such as a Th2 response. | 01-12-2012 |
20120135039 | Oral Vaccines for Producing Mucosal Immunity - Embodiments of this invention include lipid-based immunogenic compositions (adjuvants or carriers) useful for oral or gastrointestinal administration for improving mucosal immune responses in animals vaccinated for a variety of bacterial infections. In certain embodiments, lipid compositions of this invention include a mixture of fatty acids having different chain lengths, thereby providing desired physico-chemical properties. When a bacterial antigen is mixed with a lipid-based adjuvant or carrier, the resulting composition elicits improved mucosal immune responses and thereby decreases infections and sequellae of disease caused by | 05-31-2012 |
20120141534 | Vault Compositions for Immunization Against Chlamydia Genital Infection - Methods and compositions are provided herein for immunizing a subject against Chlamydial genital infection by administering to the subject an effective amount of a Chlamydial immunogenic peptide or an immunogenic fragment or variant thereof incorporated within a vault-like particle carrier. In some aspects, the vault-like-particles are administered to the nasal mucosa. The methods and compositions advantageously exhibit enhanced ability to induce cell-mediated immunity and/or antibody-based immunity at mucosal surfaces while reducing inflammation associated with | 06-07-2012 |
20130034588 | CHLAMYDIA PNEUMONIAE ASSOCIATED CHRONIC INTRAOCULAR DISORDERS AND TREATMENT THEREOF - Infection by | 02-07-2013 |
20130251749 | METHODS AND COMPOSITIONS FOR CHLAMYDIAL ANTIGENS AS REAGENTS/STRATEGIES FOR DIAGNOSIS AND TREATMENT OF CHLAMYDIAL INFECTION AND DISEASE - The present invention provides | 09-26-2013 |
20130344109 | Immunogenic Compositions - The present invention provides compositions comprising a Chlamydial major outer membrane protein (referenced herein as “MOMP”), from at least one Chlamydial serovar and an adjuvant, characterized in that the adjuvant comprises the product E6020 having CAS Number 287180-63-6. The composition may further comprise at least one carrier system (e.g., emulsion, mineral particle). The MOMP protein may be derived from any species of | 12-26-2013 |
20180021423 | METHODS AND COMPOSITIONS FOR ATTENUATED CHLAMYDIA AS VACCINE AND VECTOR | 01-25-2018 |